Solitron Devices INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
OTC.Pink
Olesen Value Fund L.P. and associated entities have filed a Schedule 13D, reporting beneficial ownership of 10.1% of Solitron Devices Inc. common stock, acquired for investment purposes.
OTC.Pink
Olesen Value Fund L.P. has reduced its beneficial ownership in Solitron Devices Inc. to 11.5% while maintaining an investment purpose and seeking shareholder value discussions.